| abstract |
Microbially produced hybrid human leukocyte interferons, comprising, in sequence, discrete subsequences corresponding in amino acid identity and number to subsequences of different, naturally occurring leukocyte interferons useful in the treatment of viral and neoplastic diseases, and means used in their production, i.e. recombinant DNA molecules coding for the amino acid sequences of these interferons, vectors capable of expressing these interferons in microbial host organisms and host organisms transformed with these vectors. |